https://vitalspanwire.com/news/lecanemab-blood-proteins-treatment-monitoring-studyVitalspan Wireen2026-09-25T16:03:15.434ZBlood-protein study identifies candidates for tracking Alzheimer’s treatmenthttps://vitalspanwire.com/news/human-brain-atlas-late-life-support-cell-gene-activityVitalspan Wireen2026-09-25T11:01:58.354ZHuman brain atlas maps late-life shifts in support-cell gene activityhttps://vitalspanwire.com/news/danegaptide-oral-diabetic-retinopathy-early-studyVitalspan Wireen2026-09-24T21:02:31.046ZDanegaptide paper advances case for testing oral treatment of diabetic retinal diseasehttps://vitalspanwire.com/news/fda-approves-onswik-weekly-insulin-type-2-diabetesVitalspan Wireen2026-09-24T16:02:11.726ZFDA approves Lilly’s once-weekly insulin Onswik for type 2 diabeteshttps://vitalspanwire.com/news/employment-instability-later-life-cognition-studyVitalspan Wireen2026-09-24T11:02:13.505ZEmployment instability linked to poorer later-life cognition in U.S. studyhttps://vitalspanwire.com/news/catestatin-peptide-neurodegeneration-tau-amyloid-mouse-studyVitalspan Wireen2026-09-23T21:02:33.907ZCatestatin peptide reduces neurodegeneration markers in mouse models